Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Hormones control reproduction and are crucial for body balance.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

Educating healthcare workers and parents about hair toe tourniquets can help prevent serious complications.

The birth control pill with only progestogen can cause a false alarm in a hormone test.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Menopause affects hair and skin; more research needed for treatment.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Women may need different blood pressure guidelines than men for heart disease prevention.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.